Household pharmaceutical attention to hypertensive patients: experience based on DADER method for pharmacotherapeutic attendance

Cristina Poll Biguelini

Abstract


The pharmacy industry is changing, taking on more responsibilities and conquering new areas. However, the main role of this professional is already not well recognized: the pharmacist role is directed to teach, guide and make pharmaceutical care as a daily practice, with a primary interest in the patient. It is in this context that the present work was carried on, aiming to classify drug-related problems (DRP) among a group of patients with hypertension, based on the Dader pharmacotherapeutic method, developed to emphasize the importance of professional performance in community health programs. We observed predominance of PRM 1 (the patient has a health problem by not using any medication you need), followed by PRM 4 (quantitative ineffectiveness of the drug). It means 53% of DRP found themselves on level of need, the level of 34.30% and 12.60% effectiveness in security. Therefore, drug therapy, when grounded over pharmaceutical care, can reduce risks and potential damage of pharmacotherapy.

Keywords


Pharmaceutical Care; Method Dader; Hypertension



DOI: http://dx.doi.org/10.14450/2318-9312.v25.e1.a2013.pp51-61

Refbacks

  • There are currently no refbacks.


Copyright (c) 2014 Infarma - Pharmaceutical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Infarma - Ciências Farmacêuticas

ISSN - 2318-9312 (Versão eletrônica)

ISSN - 0104-0219 (Versão impressa)

Conselho Federal de Farmácia - CFF

SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF

CEP: 71635-615 - Fone: (61)3878-8751

e-mail:infarma@cff.org.br

Diretoria

Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia

Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia

João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia

Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia